Discover
GOSS
Gossamer Bio, Inc.
0.17
4 x 0.16
2 x 0.16
bid
ask
+
0.00
1.88%
3 @ 04:00 PM
0.17 +0.01 (3.64%)
| Ytd | -94.59% | |
| 1y | -86.58% |
0.16
day range
0.17
0.14
52 week range
3.87
| Open | 0.17 | Prev Close | 0.16 | Low | 0.16 | High | 0.17 | Mkt Cap | 81.98M |
| Vol | 11.30M | Avg Vol | 11.93M | EPS | -0.79 | P/E | N/A | Forward P/E | -1.24 |
| Beta | 1.96 | Short Ratio | 6.29 | Inst. Own | 77.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 0.25 | 200-d Avg | 1.66 | 1yr Est | 7.61 |
| Income Statement | |||
| Total Revenue | 16.95M | ||
| Revenues (USD) | 16.95M | ||
| Gross Profit | 16.95M | ||
| Operating Expenses | 61.82M | ||
| Research and Development Expense | 43.08M | ||
| Selling, General and Administrative Expense | 18.75M | ||
| Operating Income | -44.87M | ||
| Interest Expense | 2.76M | ||
| Net Income | -46.66M | ||
| Net Income Common Stock | -46.66M | ||
| Net Income Common Stock (USD) | -46.66M | ||
| Consolidated Income | -46.66M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -43.91M | ||
| Earning Before Interest & Taxes (USD) | -43.91M | ||
| Weighted Average Shares | 234.14M | ||
| Weighted Average Shares Diluted | 234.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.03M | ||
| Cash and Equivalents (USD) | 41.03M | ||
| Investments | 58.19M | ||
| Investments Current | 58.19M | ||
| Trade and Non-Trade Receivables | 9.25M | ||
| Current Assets | 124.54M | ||
| Property, Plant & Equipment Net | 3.97M | ||
| Total Assets | 128.90M | ||
| Total Debt | 201.98M | ||
| Current Liabilities | 56.51M | ||
| Debt Non-Current | 201.98M | ||
| Total Liabilities | 290.38M | ||
| Accumulated Retained Earnings (Deficit) | -1.49B | ||
| Accumulated Other Comprehensive Income | -4.02M | ||
| Shareholders Equity | -161.48M | ||
| Shareholders Equity (USD) | -161.48M | ||
| Assets Non-Current | 4.36M | ||
| Total Debt (USD) | 201.98M | ||
| Deferred Revenue | 40.64M | ||
| Liabilities Non-Current | 233.88M | ||
| Trade and Non-Trade Payables | 10.82M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 232.00K | ||
| Net Cash Flow from Financing | 512.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.30M | ||
| Issuance (Purchase) of Equity Shares | 512.00K | ||
| Net Cash Flow from Investing | 41.61M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 41.61M | ||
| Net Cash Flow from Operations | -38.72M | ||
| Effect of Exchange Rate Changes on Cash | -101.00K | ||
| Share Based Compensation | 6.30M | ||